How will Amfi's bi-annual categorisation of stocks impact portfolio of investors and why is it necessary? Here's an explainer
As the new categorisation of stocks by mutual funds industry body, the Association of Mutual Funds in India (Amfi) will be effective from August 1. Here are the details investors need to know. The categorisation done on half yearly basis will be valid till January next year.
Q. What are the key changes from August 1?
The market capitalisation cut off for large-cap stocks is at Rs49,700 crore, whereas it is Rs17,400 crore for midcaps. Of the total market cap, large-cap stocks attribute 68.3 percent in the August list, as compared to 69.4 percent in the review done in January. As the midcap segment made a spectacular rally, these stocks attribute 16.6 percent in the August list as against 16 percent in January review. Similarly, even in the lower segment, smallcaps attribute 15.1 percent in August list versus 14.6 percent in January review. All the fresh listings have debuted in the small cap category. However, Mankind Pharma, with a current market cap of Rs69,716 crore, has made a direct entry into the large-cap segment. Shares of Mankind Pharma have surged over 60 percent over its issue price.
Q. What are big shake-ups in the new list?